Imprese · 30/03/19941 min di lettura
Akorn, Inc., et al.; Withdrawal of Approval of 18 Abbreviated Antibiotic Applications
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is withdrawing approval of 18 abbreviated antibiotic applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.